CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 67 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $736,000 | +1.8% | 71,478 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $723,000 | -0.3% | 71,478 | +10.8% | 0.00% | 0.0% |
| Q2 2016 | $725,000 | -5.1% | 64,532 | +15.4% | 0.00% | 0.0% |
| Q1 2016 | $764,000 | -26.5% | 55,931 | +2.0% | 0.00% | 0.0% |
| Q4 2015 | $1,040,000 | +1.9% | 54,822 | +0.8% | 0.00% | 0.0% |
| Q3 2015 | $1,021,000 | +26.2% | 54,379 | +0.1% | 0.00% | 0.0% |
| Q2 2015 | $809,000 | +3945.0% | 54,338 | +3949.0% | 0.00% | – |
| Q1 2015 | $20,000 | +33.3% | 1,342 | +21.3% | 0.00% | – |
| Q4 2014 | $15,000 | +7.1% | 1,106 | 0.0% | 0.00% | – |
| Q3 2014 | $14,000 | +27.3% | 1,106 | +3.8% | 0.00% | – |
| Q2 2014 | $11,000 | -95.2% | 1,066 | -93.7% | 0.00% | – |
| Q1 2014 | $229,000 | – | 17,052 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,149,120 | $14,559,000 | 2.72% |
| Corriente Advisors, LLC | 680,000 | $8,595,000 | 2.05% |
| ACUTA CAPITAL PARTNERS, LLC | 537,500 | $6,794,000 | 1.85% |
| INGALLS & SNYDER LLC | 1,362,203 | $17,218,000 | 0.85% |
| Kensington Investment Counsel, LLC | 75,533 | $955,000 | 0.79% |
| SPHERA FUNDS MANAGEMENT LTD. | 384,039 | $4,854,000 | 0.43% |
| Opaleye Management Inc. | 254,000 | $3,211,000 | 0.42% |
| RA Capital Management | 1,823,520 | $23,049,000 | 0.32% |
| Perceptive Advisors | 2,150,641 | $27,184,000 | 0.29% |
| Parkman Healthcare Partners LLC | 50,290 | $636,000 | 0.16% |